Samir Ounzain

Company: HAYA Therapeutics

Job title: Chief Executive Officer & Co-Founder

Seminars:

Translating Discovery of Novel LncRNA Targets into Clinical Programs 11:15 am

Discovering high-value LncRNA targets to reprogram diseased cell states Understanding underlying LncRNA and target biology to curate preclinical and clinical strategy Building smooth drug development strategy and uncovering robust biomarkers for smooth recruitment and progressionRead more

day: Day 2

Pioneers’ Panel: Shedding a Light on the Value of the Dark Genome to Raise Awareness & Educate the Wider Community 8:30 am

Highlighting the vast potential of the dark genome across a range of disease indications to grow appreciation for targeted therapeutics Discussing common investor concerns and how to address these to promote funding in the field How can we demonstrate proof of concept and improved standard of care for dark genome therapeutics?Read more

day: Day 1